Ebola may soon be a “preventable and treatable” disease after a trial of two drugs showed significantly improved survival rates.
Four drugs were tried on patients in the Democratic Republic of Congo, where there is a major outbreak of the virus.
Two of the drug were considerably more effective in treating the disease. Health officials say the drugs will now be used to treat all Ebola patients in D.R. Congo.
Advertisement
The US National Institute of Allergy and Infectious Diseases (NIAID), which co-sponsored the trial, said the results are “very good news” for the fight against Ebola.
The drugs work by attacking the Ebola virus with antibodies, neutralising its impact on human cells.
Related posts:
Congo deploys experimental Ebola treatment as cases rise
Ebola treatment centre in Congo reopens after attack
Deaths from Congo’s Ebola exceeds 1,000 as attacks on treatment centres continue
Dexamethasone: WHO DG lauds UK for breakthrough in COVID-19 treatment
U.K Scientists begin Clinical trials of COVID-19 Vaccine
Roche wins FDA’s breakthrough therapy label for autism drug
Ebola vaccines arrive in Uganda for trials
Uganda opens two Ebola treatment units in the border with the DRC
